HCA Healthcare (NYSE:HCA) Receives “Overweight” Rating from Cantor Fitzgerald

Cantor Fitzgerald reiterated their overweight rating on shares of HCA Healthcare (NYSE:HCAFree Report) in a research note released on Tuesday morning, Benzinga reports. They currently have a $335.00 price target on the stock.

Other analysts also recently issued research reports about the company. StockNews.com upgraded HCA Healthcare from a buy rating to a strong-buy rating in a report on Monday, July 1st. Oppenheimer boosted their price objective on HCA Healthcare from $330.00 to $345.00 and gave the stock an outperform rating in a report on Monday, April 29th. Deutsche Bank Aktiengesellschaft boosted their price objective on HCA Healthcare from $359.00 to $375.00 and gave the stock a buy rating in a report on Friday, June 28th. Wells Fargo & Company upped their target price on HCA Healthcare from $303.00 to $315.00 and gave the company an equal weight rating in a report on Thursday, March 28th. Finally, Royal Bank of Canada upped their target price on HCA Healthcare from $322.00 to $329.00 and gave the company an outperform rating in a report on Monday, April 29th. Four research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, HCA Healthcare presently has a consensus rating of Moderate Buy and an average target price of $326.53.

View Our Latest Analysis on HCA Healthcare

HCA Healthcare Stock Performance

HCA stock opened at $316.79 on Tuesday. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26. The company has a 50-day simple moving average of $326.96 and a 200 day simple moving average of $319.44. HCA Healthcare has a fifty-two week low of $215.96 and a fifty-two week high of $344.20. The company has a market capitalization of $82.97 billion, a P/E ratio of 15.79, a PEG ratio of 1.48 and a beta of 1.68.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings results on Friday, April 26th. The company reported $5.36 EPS for the quarter, topping the consensus estimate of $5.01 by $0.35. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The firm had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. During the same period in the previous year, the business earned $4.93 earnings per share. HCA Healthcare’s revenue for the quarter was up 11.2% compared to the same quarter last year. Sell-side analysts predict that HCA Healthcare will post 20.97 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, June 28th. Stockholders of record on Friday, June 14th were issued a dividend of $0.66 per share. The ex-dividend date was Friday, June 14th. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.83%. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.16%.

Insider Transactions at HCA Healthcare

In other news, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total transaction of $303,576.00. Following the completion of the transaction, the senior vice president now directly owns 22,365 shares in the company, valued at $6,977,880. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In related news, SVP Kathryn A. Torres sold 1,863 shares of the company’s stock in a transaction on Wednesday, May 15th. The stock was sold at an average price of $326.18, for a total value of $607,673.34. Following the completion of the transaction, the senior vice president now directly owns 19,612 shares in the company, valued at $6,397,042.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total value of $303,576.00. Following the completion of the transaction, the senior vice president now owns 22,365 shares of the company’s stock, valued at $6,977,880. The disclosure for this sale can be found here. Insiders sold a total of 12,397 shares of company stock worth $3,921,929 over the last three months. 1.70% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of HCA. Creative Planning raised its stake in HCA Healthcare by 25.4% during the third quarter. Creative Planning now owns 36,273 shares of the company’s stock worth $8,922,000 after acquiring an additional 7,350 shares in the last quarter. Comerica Bank raised its stake in HCA Healthcare by 623.3% during the third quarter. Comerica Bank now owns 43,502 shares of the company’s stock worth $10,701,000 after acquiring an additional 37,488 shares in the last quarter. Public Sector Pension Investment Board grew its holdings in shares of HCA Healthcare by 9.1% during the third quarter. Public Sector Pension Investment Board now owns 21,560 shares of the company’s stock worth $5,303,000 after purchasing an additional 1,804 shares during the last quarter. Alamar Capital Management LLC grew its holdings in shares of HCA Healthcare by 3.8% during the third quarter. Alamar Capital Management LLC now owns 12,048 shares of the company’s stock worth $2,964,000 after purchasing an additional 440 shares during the last quarter. Finally, Fortis Group Advisors LLC grew its holdings in shares of HCA Healthcare by 1.5% during the third quarter. Fortis Group Advisors LLC now owns 22,822 shares of the company’s stock worth $6,018,000 after purchasing an additional 338 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

About HCA Healthcare

(Get Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.